tradingkey.logo
tradingkey.logo
Suchen

LENSAR Inc

LNSR
Zur Watchlist hinzufügen
5.540USD
-0.290-4.97%
Handelsschluss 05/15, 16:00ETKurse um 15 Minuten verzögert
67.04MMarktkapitalisierung
2.27KGV TTM

mehr Informationen über LENSAR Inc Unternehmen

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.

LENSAR Inc Informationen

BörsenkürzelLNSR
Name des UnternehmensLENSAR Inc
IPO-datumSep 21, 2020
CEOCurtis (Nicholas T)
Anzahl der mitarbeiter140
WertpapierartOrdinary Share
GeschäftsjahresendeSep 21
Addresse2800 Discovery Drive
StadtORLANDO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl32826
Telefon18885367271
Websitehttps://www.lensar.com/
BörsenkürzelLNSR
IPO-datumSep 21, 2020
CEOCurtis (Nicholas T)

Führungskräfte von LENSAR Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
+7.35%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
+1.34%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
+2.99%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
+7.93%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
+8.36%
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
+7.35%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
+1.34%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
+2.99%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
+7.93%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
+8.36%
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
34.31M
66.43%
Europe
8.43M
16.31%
Asia (excluding South Korea)
8.02M
15.53%
South Korea
658.00K
1.27%
Other
238.00K
0.46%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
North Run Capital, LP
9.35%
Brandes Investment Partners, L.P.
7.07%
Curtis (Nicholas T)
7.06%
BlackRock Institutional Trust Company, N.A.
4.84%
Link (William J)
4.55%
Andere
67.12%
Aktionäre
Aktionäre
Anteil
North Run Capital, LP
9.35%
Brandes Investment Partners, L.P.
7.07%
Curtis (Nicholas T)
7.06%
BlackRock Institutional Trust Company, N.A.
4.84%
Link (William J)
4.55%
Andere
67.12%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
27.45%
Individual Investor
21.79%
Hedge Fund
11.93%
Investment Advisor/Hedge Fund
7.97%
Pension Fund
1.40%
Bank and Trust
1.34%
Research Firm
1.11%
Andere
27.02%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
172
6.68M
55.41%
-342.76K
2025Q4
162
5.97M
49.99%
-603.16K
2025Q3
148
5.64M
47.18%
-98.25K
2025Q2
124
7.77M
65.87%
+342.80K
2025Q1
115
7.48M
63.69%
+236.19K
2024Q4
93
7.07M
60.29%
-575.26K
2024Q3
87
7.23M
62.19%
-377.24K
2024Q2
90
7.17M
61.87%
-380.16K
2024Q1
87
6.85M
59.77%
-601.54K
2023Q4
89
6.81M
60.46%
-688.43K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
North Run Capital, LP
1.10M
9.21%
--
--
Mar 23, 2025
Brandes Investment Partners, L.P.
856.22K
7.17%
+78.51K
+10.10%
Dec 31, 2025
Curtis (Nicholas T)
792.29K
6.63%
--
--
Oct 24, 2025
BlackRock Institutional Trust Company, N.A.
585.69K
4.9%
+10.13K
+1.76%
Dec 31, 2025
Link (William J)
543.27K
4.55%
-7.37K
-1.34%
Oct 24, 2025
Connaughton (Alan B.)
274.57K
2.3%
-2.39K
-0.86%
Feb 18, 2026
Lindstrom (Richard L)
239.04K
2%
-7.37K
-2.99%
Oct 24, 2025
Dimensional Fund Advisors, L.P.
224.93K
1.88%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
217.73K
1.82%
-156.00
-0.07%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
Mehr Anzeigen
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.02%
iShares Micro-Cap ETF
Anteil0.02%
iShares Russell 2000 Growth ETF
Anteil0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.01%
Franklin US Small Cap Multifactor Index ETF
Anteil0.01%
iShares Russell 2000 ETF
Anteil0%
Proshares Ultra Russell 2000
Anteil0%
ProShares Hedge Replication ETF
Anteil0%
ProShares UltraPro Russell2000
Anteil0%
Global X Russell 2000 ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI